Literature DB >> 3701514

Celiac disease in insulin-dependent diabetes mellitus.

E Savilahti, O Simell, S Koskimies, A Rilva, H K Akerblom.   

Abstract

Jejunal biopsy was performed without selection in 110 of 201 children with insulin-dependent diabetes mellitus; serum reticulin antibody, antigliadin antibody by enzyme-linked immunosorbent assay, and serum IgA were studied in all 201 children. Seven children had severe jejunal villous atrophy, giving a prevalence of celiac disease of at least 3.5%. Of the serum tests used, antigliadin antibody with ELISA was the most sensitive. Four patients adhered to a gluten-free diet, and their jejunal structure became normal; three had subsequent gluten provocation, and the jejunal mucosa relapsed in every one. Six had HLA-B8 and -DR3 antigens, and one had B15 and -DR4 phenotypes. In most patients, a gluten-free diet had little effect on insulin dosage, urinary excretion of glucose, or serum level of hemoglobin A1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3701514     DOI: 10.1016/s0022-3476(86)81042-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  19 in total

1.  A prospective study of the prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency.

Authors:  M R Howard; A J Turnbull; P Morley; P Hollier; R Webb; A Clarke
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

2.  Celiac disease in an adult Turkish population with type 1 diabetes mellitus.

Authors:  Cem Aygun; Suleyman Uraz; Taner Damci; Zeynep Osar; Volkan Yumuk; Emine Akdenizli; Hasan Ilkova
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

3.  Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features.

Authors:  Farid H Mahmud; Joseph A Murray; Yogish C Kudva; Alan R Zinsmeister; Ross A Dierkhising; Brian D Lahr; Peter J Dyck; Robert A Kyle; Mounif El-Youssef; Lawrence J Burgart; Carol T Van Dyke; Deanna L Brogan; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2005-11       Impact factor: 7.616

Review 4.  Co-occurrence of type 1 diabetes mellitus and celiac disease.

Authors:  Amit Akirov; Orit Pinhas-Hamiel
Journal:  World J Diabetes       Date:  2015-06-10

5.  Jejuna of patients with insulin-dependent diabetes mellitus (IDDM) show signs of immune activation.

Authors:  E Savilahti; T Ormälä; T Saukkonen; U Sandini-Pohjavuori; J M Kantele; A Arato; J Ilonen; H K Akerblom
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 6.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

7.  Effect of gluten-free diet and adherence on growth and diabetic control in diabetics with coeliac disease.

Authors:  O I Saadah; M Zacharin; A O'Callaghan; M R Oliver; A G Catto-Smith
Journal:  Arch Dis Child       Date:  2004-09       Impact factor: 3.791

8.  IgA anti-endomysial antibodies on human umbilical cord tissue for celiac disease screening. Save both money and monkeys.

Authors:  U Volta; N Molinaro; L de Franceschi; D Fratangelo; F B Bianchi
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

9.  Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine.

Authors:  Mariantonia Maglio; Fiorella Florian; Monica Vecchiet; Renata Auricchio; Francesco Paparo; Raffaella Spadaro; Delia Zanzi; Luciano Rapacciuolo; Adriana Franzese; Daniele Sblattero; Roberto Marzari; Riccardo Troncone
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

10.  Age at development of type 1 diabetes- and celiac disease-associated antibodies and clinical disease in genetically susceptible children observed from birth.

Authors:  Satu Simell; Sanna Hoppu; Tuu Simell; Marja-Riitta Ståhlberg; Markku Viander; Taina Routi; Ville Simell; Riitta Veijola; Jorma Ilonen; Heikki Hyöty; Mikael Knip; Olli Simell
Journal:  Diabetes Care       Date:  2010-01-07       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.